Yellow Fever

Fièvre jaune, dengue... : Sanofi investit plus que jamais dans les vaccins

Rénovation du site de Val de Reuil, dans l'Eure, usine prête à produire à Neuville sur Saône, près de Lyon… Sanofi investit plus que jamais dans les vaccins. Il détient déjà 20 % de ce marché, en seconde place, à quelques milliers de doses près, derrière le géant britannique GSK qui a repris en avril la branche vaccin de Novartis. Le secteur est concentré entre quatre acteurs: Sanofi, GSK, l'allemand Merck et l'américain Pfizer qui ne commercialise qu'un vaccin, le Prevnar, mais en tire un chiffre d'affaires de plus de 4 milliards de dollars.

Undefined

World Health Assembly closes

The Sixty-seventh World Health Assembly closed today, after adopting more than 20 resolutions on public health issues of global importance.
 
“This has been an intense Health Assembly, with a record-breaking number of agenda items, documents and resolutions, and nearly 3 500 registered delegates,” said Dr Margaret Chan, WHO’s Director-General. “This is a reflection of the growing number of complexity of health issues, and your deep interest in addressing them.”
 
Undefined

Vaccinating Children Beyond the ‘Cold Chain’: Extending the Heat Stability of Vaccines

Shipping and storing vaccines in a ‘cold chain’ in the tropical heat of many resource-limited countries – whereby the vaccine is kept at temperatures between 2°C to 8°C from the point of manufacture until reaching the recipient – is a tremendous challenge and a major cause of poor immunisation coverage rates.
Undefined

Congo-Brazzaville: Semaine africaine de vaccination - Les femmes en âge de procréer seront vaccinées contre le tétanos

À l'instar d'autres pays africains, la RDC organise cette semaine de vaccination lancée depuis le 21 avril par le ministre de la Santé publique, le Dr Félix Kabange Numbi, au centre de santé Élonga à Masina.
 
Undefined

Afrique: Les cas de fièvre jaune en baisse et passent à 2%

Un officiel du gouvernement zambien a déclaré que ce pays d'Afrique australe a réussi à réduire les cas de fièvre jaune à environ 2 %.

Undefined

Millions of Nigeria children in danger as country runs out of vaccines

An estimated six to seven million Nigerian children of immunizable age are in danger of dying from vaccine-preventable diseases this year, if the Federal Government fails to intervene in the current stock out of vaccines in the country, a body of scientists is warning.
The impact may not be fully felt yet as some states still rely on reserves. Lagos State, for instance, says it still has a three-month supply of BCG (given at birth against tuberculosis) OPV (oral polio virus), Pentavalent combination, measles, yellow fever and tetanus toxoid vaccines).
Undefined

Dubai Health Authority in dilemma over shortage of Yellow Fever vaccine

Travel plans of thousands of people are in a quandary as a global shortage of Yellow Fever vaccine has affected the UAE as well. A senior official from the Dubai Health Authority (DHA) said on Tuesday that the shortage has been persisting for the last two months.
 
Undefined

Yellow fever vaccine production delay affects international travellers

A temporary production delay for the yellow fever vaccine has caused a shortage across North America.
 
It's affecting international travellers and the deputy medical officer of health for the Saskatoon Health Region says only people going to countries with a high risk of the mosquito-carrying disease are guaranteed to receive the shot.
 
Undefined

Le Soudan frappé par la fièvre jaune

L’Organisation mondiale de la Santé (OMS) signale une nouvelle flambée de fièvre jaune au Soudan.Douze villes du centre du pays sont frappées. Entre le 3 octobre et le 24 novembre, 44 cas suspects ont été recensés. Dont 14 mortels. Soit un taux de létalité de 32%.

Undefined

Pages